BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31336697)

  • 1. Comparison of Polydopamine-Coated Mesoporous Silica Nanorods and Spheres for the Delivery of Hydrophilic and Hydrophobic Anticancer Drugs.
    Pada AK; Desai D; Sun K; Prakirth Govardhanam N; Törnquist K; Zhang J; Rosenholm JM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
    Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
    Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
    Li X; Xie C; Xia H; Wang Z
    Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
    Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
    Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart MSN-Drug-Delivery System for Tumor Cell Targeting and Tumor Microenvironment Release.
    Dong JH; Ma Y; Li R; Zhang WT; Zhang MQ; Meng FN; Ding K; Jiang HT; Gong YK
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42522-42532. PubMed ID: 34463488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the anti-cancer activity of a mesoporous silica nanoparticle surface coated with polydopamine loaded with umbelliprenin.
    Edalatian Tavakoli S; Motavalizadehkakhky A; Homayouni Tabrizi M; Mehrzad J; Zhiani R
    Sci Rep; 2024 May; 14(1):11450. PubMed ID: 38769394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive enhanced photodynamic therapy and enhanced chemotherapy fighting against malignant tumors with sequential drug release.
    Yang Y; Zhang X; Bai Z; Cui Z; Liang W; Zhang J; Li K; Shi M; Liu Z; Wang J; Li J
    Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.
    Li Y; Duo Y; Bao S; He L; Ling K; Luo J; Zhang Y; Huang H; Zhang H; Yu X
    Int J Nanomedicine; 2017; 12():6239-6257. PubMed ID: 28894364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance.
    Cheng W; Liang C; Xu L; Liu G; Gao N; Tao W; Luo L; Zuo Y; Wang X; Zhang X; Zeng X; Mei L
    Small; 2017 Aug; 13(29):. PubMed ID: 28594473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
    Wei Y; Gao L; Wang L; Shi L; Wei E; Zhou B; Zhou L; Ge B
    Drug Deliv; 2017 Nov; 24(1):681-691. PubMed ID: 28414557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.
    Feng Y; Li NX; Yin HL; Chen TY; Yang Q; Wu M
    Mol Pharm; 2019 Jan; 16(1):422-436. PubMed ID: 30525641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-coated interfacial layer at organic/inorganic phase for temporally controlling dual-drug delivery from electrospun fibers.
    Zhao X; Zhao J; Lin ZY; Pan G; Zhu Y; Cheng Y; Cui W
    Colloids Surf B Biointerfaces; 2015 Jun; 130():1-9. PubMed ID: 25879640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
    Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
    Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 17. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
    Yuan X; Peng S; Lin W; Wang J; Zhang L
    J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-cloaked polydopamine modified mesoporous silica nanoparticles for cancer therapy.
    Wang Z; Shi J; Pan H; Liu M; Sang Y; Ai J; Liu Y; Chen L
    Nanotechnology; 2022 Jun; 33(34):. PubMed ID: 35576909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
    Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
    Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
    Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y
    Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.